EMAGine
Zug
About EMAGine
EMAGine is a relatively new ophthalmic treatment that uses UV-light and riboflavin.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $10.5K
- Last round: Grant (Aug 2012)
- Website: emagine-eye.com
Industries & Categories
Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/emagine-2680314 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.